Search research articles
Contact Us
Filters
Showing results (251-260 of 292) with videos related to
Page
of 30
Sort By:
Current Oncology (Toronto, Ont.)
|
May 26, 2023
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, et al.
Critical Reviews in Oncology/Hematology
|
September 9, 2015
Public health value of universal HPV vaccination
Riccardo A Audisio, Giancarlo Icardi, Andrea M Isidori, et al.
Cancers
|
July 29, 2023
Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study
Fabrizio Nelli, Carlo Signorelli, Agnese Fabbri, et al.
International Immunopharmacology
|
April 23, 2022
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study
Fabrizio Nelli, Agnese Fabbri, Valentina Panichi, et al.
Acta Bio-Medica : Atenei Parmensis
|
April 11, 2020
The campaign "This Is Public Health" in Italy, set up by a team of Public Health Schools in Northern Italy
Daria Bucci, Deanna Rossi, Roberto Croci, et al.
European Journal of Public Health
|
March 25, 2025
Competency-based and problem-based learning methodologies: the WHO and ISS European Public Health Leadership Course
Donatella Barbina, Joao Breda, Alfonso Mazzaccara, et al.
Acta Bio-Medica : Atenei Parmensis
|
February 2, 2021
SARS-CoV-2/COVID-19 Testing: The Tower of Babel
Chiara Reno, Jacopo Lenzi, Davide Golinelli, et al.
Scientific Reports
|
December 19, 2022
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients
Enzo Maria Ruggeri, Fabrizio Nelli, Diana Giannarelli, et al.
Clinical and Experimental Medicine
|
January 20, 2024
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, et al.
Environmental Research
|
April 27, 2020
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study
Maria Fiore, Roberto Parisio, Tommaso Filippini, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 292) with videos related to
Sort By:
Page
of 30
Current Oncology (Toronto, Ont.)
|
May 26, 2023
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, et al.
Critical Reviews in Oncology/Hematology
|
September 9, 2015
Public health value of universal HPV vaccination
Riccardo A Audisio, Giancarlo Icardi, Andrea M Isidori, et al.
Cancers
|
July 29, 2023
Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study
Fabrizio Nelli, Carlo Signorelli, Agnese Fabbri, et al.
International Immunopharmacology
|
April 23, 2022
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study
Fabrizio Nelli, Agnese Fabbri, Valentina Panichi, et al.
Acta Bio-Medica : Atenei Parmensis
|
April 11, 2020
The campaign "This Is Public Health" in Italy, set up by a team of Public Health Schools in Northern Italy
Daria Bucci, Deanna Rossi, Roberto Croci, et al.
European Journal of Public Health
|
March 25, 2025
Competency-based and problem-based learning methodologies: the WHO and ISS European Public Health Leadership Course
Donatella Barbina, Joao Breda, Alfonso Mazzaccara, et al.
Acta Bio-Medica : Atenei Parmensis
|
February 2, 2021
SARS-CoV-2/COVID-19 Testing: The Tower of Babel
Chiara Reno, Jacopo Lenzi, Davide Golinelli, et al.
Scientific Reports
|
December 19, 2022
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients
Enzo Maria Ruggeri, Fabrizio Nelli, Diana Giannarelli, et al.
Clinical and Experimental Medicine
|
January 20, 2024
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, et al.
Environmental Research
|
April 27, 2020
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study
Maria Fiore, Roberto Parisio, Tommaso Filippini, et al.
Page
of 30